Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-29

FDA Approved: NIFEDIPINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' Original Application for nifedipine, a calcium channel blocker used to treat hypertension and angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

ORIG AP for NIFEDIPINE (NIFEDIPINE)